(MUSIC) GOOD MORNING EVERYBODY AND
WELCOME TO THE BALANCING ACT.
WE'RE SO GLAD YOU JOINED US THIS MORNING.
I'M JULIE MORAN.
AND I'M OLGA VILLAVERDE.
TODAY WE'LL BE TALKING ABOUT IMPROVING QUALITY
OF LIFE WHEN IT COMES TO THE VERY REAL
MEDICAL ISSUE OF INCONTINENCE.
IN FACT, NEARLY 3 MILLION AMERICANS SUFFER FROM IT
AT SOME LEVEL.
AND WE'VE GOT SOME HIGH TECH SOLUTIONS
FOR THE ONES WE LOVE.
PLUS, PSORIASIS.
IT'S A CONDITION EFFECTING
NEARLY 5 MILLION AMERICAN MEN AND WOMEN.
AND IN IT'S MOST SEVERE FORM, IT POSES A VERY SERIOUS HEALTH
PROBLEM.
WE'RE GOING TO HAVE THAT STORY FOR YA.
AND THE BALANCING ACT STARTS RIGHT NOW.
IT'S A REALITY WE ALL FACE- AGING.
AND FOR A GROWING NUMBER OF AMERICANS SENIORS,
PART OF THAT AGING PROGRESS INCLUDES INCONTINENCE.
AS WE OBSERVE BOTH NATIONAL CAREGIVERS AND BLADDER HEALTH
MONTH, JOINING US TO HIGHLIGHT
PRACTICAL SOLUTIONS FOR A PROBLEM
IMPACTING, NOT ONLY SENIORS, BUT THEIR CAREGIVERS AS WELL,
IS PHILIPPA LEWIS, CEO FOR SIMAVITA, PRODUCERS OF
BREAKTHROUGH TECHNOLOGY; INNOVATIVE
TECHNOLOGY, HELPING TO IMPROVE THE LIVES
OF THOSE EFFECTED BY INCONTINENCE.
GOOD MORNING.
GOOD MORNING, OLGA.
THANKS FOR BEING HERE.
PLEASURE.
NOW LET'S TALK ABOUT INCONTINENCE.
WHEN IT COMES TO INCONTINENCE, WHAT DO SENIORS AND THOSE WHO
CARE FOR THEM EXPERIENCE?
WELL, FIRSTLY SENIORS, THEY EXPERIENCE A TREMENDOUS AMOUNT
OF LOSS OF DIGNITY.
LOSS OF POWER.
AND AS A RESULT OF THEIR INCONTINENCE WHICH TENDS
TO GROW COMPULSORY.
WHEN YOU GET OLDER, YOU SIMPLY DO BECOME INCONTINENT.
IT'S A FACTOR OF AGING.
REALITY?
IT'S A REALITY AND I OFTEN SAY TO PEOPLE, YOU WANT GROW OLD?
AND THAT'S GREAT, BUT PART OF AGING IS CERTAINLY SOME
DISABILITIES.
ONE OF WHICH IS INCONTINENCE.
WHEN YOU BECOME INCONTINENT AND YOU'RE VERY ELDERLY,
IT'S A VERY UNDIGNIFIED THING.
YOU LOSE CONTROL OF YOUR BLADDER AND PERHAPS YOUR BOWEL AS WELL.
AH HUM.
AND THEN YOU'RE TOTALLY DEPENDENT UPON YOUR CARERS.
NOW TO THE CARERS, OF COURSE, IT'S TREMENDOUS BURDEN FOR THEM.
TO BE LOOKING AFTER AN ELDERLY PERSON IS SOMETIMES, JOYFUL
IN SOME RESPECTS, BUT THE REALLY BAD PART OF IT IS OFTEN
THE INCONTINENCE BECAUSE MOST OF YOUR DAY IS REALLY
DOMINATED BY THE CARE OF THEIR INCONTINENCE.
IT'S A MAJOR, MAJOR CHALLENGE FOR CARE WORKERS.
AND ONCE OF THE WORST PARTS OF THEIR JOB, LET'S SAY.
SO, THIS IS WHERE WE NEED TO LOOK AT IMPROVEMENTS, IF YOU
LIKE.
ABSOLUTELY.
BECAUSE, IT'S REALLY THE MOST EXPENSIVE PART OF THE CARE OF
THAT ELDERLY PERSON AS WELL.
WHICH A LOT OF PEOPLE DON'T KNOW.
AND I LOVE YOUR COMPANIES MISSION STATEMENT, AND
I'M GOING TO READ IT, IF I MAY.
AND I'M GONNA QUOTE, "TO PROVIDE A RICHER QUALITY OF
LIFE FOR OLDER PEOPLE, IMPROVING DIGNITY AND GRACE."
END QUOTE.
TELL ME HOW YOUR COMPANY IS MAKING A REALITY.
WE ARE DEDICATED TO ELDERLY PEOPLE HAVING BETTER QUALITY OF
LIFE.
SO WE'VE FOCUSED ON ONE AREA THAT REALLY NEGATIVELY EFFECTS
THEIR QUALITY OF LIFE.
AND THAT'S THEIR INCONTINENCE.
SO, EVERYTHING ABOUT THE COMPANY AND THE TECHNOLOGY HAS
HAD THAT AS ITS FOCUS.
THAT'S OUR CORE MISSION-
IS TO IMPROVE THEIR CARE.
AND SPEAKING OF THAT TECHNOLOGY, YOU BROUGHT A SIM DEVICE.
SHOW ME HOW IT WORKS AND WHAT IT IS.
I DID.
SO, WHAT WE'VE DEVELOPED AT SIMAVITA IS THE WORLD'S
FIRST 72 HOUR ASSESSMENT FOR INCONTINENCE.
AH HUM.
SO LET ME EXPLAIN WHAT THAT IS.
CURRENTLY, WE ACCESS ELDERLY PEOPLE FOR THEIR INCONTINENCE,
BUT IT'S A VERY MANUAL ACTIVITY.
VERY TIME CONSUMING, LABOR INTENSIVE AND RESULTS IN
BAD OUTCOMES.
SO WE'VE INSTRUMENTED THAT 72 HOURS.
AND DURING THAT 72 HOURS, OUR RESIDENTS, OR PATIENTS-THE
ELDERLY FOLK WHO ARE SUFFERING FROM INCONTINENCE,
WEAR A SMART DIAPER LIKE THIS.
AND ATTACHED TO THAT IS OUR SIM POD.
OH.
SO WE ATTACH IT THIS WAY, LIKE SO.
EASY ATTACHMENT.
UMM HUMM.
AND IT'S WORN FOR 72 HOURS BY THE ELDERLY PERSON.
AND WE CHANGE IT EVERY FEW HOURS OF COURSE.
OKAY.
BUT DURING THAT TIME, WE'RE COLLECTING ALL THE INFORMATION
THAT'S GOING ON INSIDE THE DIAPER.
THAT MEANS, THAT AT THE END OF THE 72 HOURS,
WE HAVE WHAT WE CALL, A LIVE BLADDER CHART.
AHHH.
THAT'S A COMPLETELY UNIQUE OVERVIEW OF THAT PERSON'S
INCONTINENCE PROFILE.
WE PICK UP EVERY FORM OF LEAKAGE,
YOU COULD SAY, THAT OCCURS INSIDE THE DIAPER.
AND THAT'S IMPORTANT INFORMATION BECAUSE?
IT'S VERY IMPORTANT INFORMATION BECAUSE, IF YOU UNDERSTAND
THE PATTERN OF THE PERSON'S INCONTINENCE, YOU CAN
ACTUALLY KEEP THEM CONTINENT LONGER.
YOU CAN TAKE THEM TO THE BATHROOM, WHEN THEY NEED TO GO.
SO WHAT THIS CLEVER TECHNOLOGY DOES, IS IT,
CALCULATES THROUGH AN ALGORITHM, WHEN IS THE OPTIMAL TIME
TO TAKE YOU TO THE BATHROOM.
THAT KEEPS YOU DRYER AND MORE CONTINENT.
THAT'S WHAT I WAS GOING TO ASK YOU, BECAUSE AS A
RESULT OF THIS, WOULD THAT INDIVIDUAL REACH CONTINENCE
FASTER THAN, LET'S SAY THE INDIVIDUAL THAT JUST
USES THE TRADITIONAL PADS?
THAT'S A REALLY GOOD QUESTION.
SO, WHAT'S IMPORTANT ABOUT THIS IS, AT LEAST 25%
OF ELDERLY PEOPLE WHO ENTER INTO LONG TERM CARE
FACILITIES IN THE UNITED STATES, ARE REASONABLY CONTINENT.
WITHIN 30 DAYS, THEY'RE VERY INCONTINENT.
UMMMM.
AND THE REASON FOR THAT IS, WE ACTUALLY STOP ASSISTING THEM
TO GO THE BATHROOM AT THE RIGHT TIME.
NO ONE'S FAULT, BECAUSE WITHOUT THIS TECHNOLOGY, WE
DON'T KNOW (UNISON) SO WHAT HAPPENS IS, ULTIMATELY
AND VERY QUICKLY, THEY WILL LOSE THEIR BLADDER
CONTROL.
HENCE, THEY BECOME HIGHLY RELIANT UPON DIAPERS.
AND THEY BECOME VERY INCONTINENT.
THAT'S THE GATEWAY FOR ALL THESE COSTS TO BLOW OUT.
AND FOR THE CARE OF THAT ELDERLY PERSON TO BECOME VERY ONEROUS
AND DIFFICULT.
AND TERRIBLE FOR THE ELDERLY PERSON AND
EVEN WORSE FOR THE CAREGIVER WHO'S TRYING TO KEEP THEM
CONTINENT.
THEY HAVE NO HOPE WITHOUT THIS SORT OF TECHNOLOGY.
GREAT INFORMATION.
I WANT YOU STAY RIGHT THERE, PHILIPPA
BECAUSE WHEN WE COME BACK, WE'RE GOING TO HEAR
FROM A HEALTH CARE PROVIDER, OFFERING HER UNIQUE PERSPECTIVE
ON INCONTINENCE TECHNOLOGY AS GROUNDBREAKING INNOVATIONS
CONTINUE TO IMPROVE LIVES, RESTORE INDEPENDENCE AND
OFFER GREATER DIGNITY TO THOSE EFFECTED.
THE BALANCING ACT WILL BE RIGHT BACK.
STAY RIGHT THERE.
(MUSIC)
I LOVE SIM FOR SO MANY THINGS.
FOR ONE, IT PROVIDES US AN ACCURATE ASSESSMENT.
IT ALLOWS US TO BE ABLE COLLABORATIVELY WITH RESIDENTS
AND FAMILIES, UMMM, TO, YOU KNOW, ESTABLISH INDIVIDUAL
TOILETING PROGRAMS.
IT GIVES THE RESIDENTS BACK THEIR DIGNITY.
UMMM, IT ALLOWS PRIVACY.
THE STAFF ABSOLUTELY LOVE IT'S ABILITY TO GIVE ACCURATE
ASSESSMENT.
WE'RE TOILETING PEOPLE WHEN THEY NEED TO BE TOILETED.
IT ALLOWS US TO INTEGRATE THEM WITH STAFF, INTO MORE SOCIAL
ACTIVITIES AND YOU KNOW, TO DEVELOPING RELATIONSHIPS.
FROM THE OTHER COSTS, POINT OF VIEW, CERTAINLY IT INCREASES
OUR FUNDING.
WE'RE ABLE TO VALIDATE, UMMM, INCONTINENCE.
WE'RE ALSO ABLE A VALIDATE A TOILETING PROGRAM.
UMMM, THE NEXT THING IT DOES; IT ACTUALLY SAVES US IN TERMS
OF OUR CONTINENCE AIDES.
WE WERE OVER-PADDING.
THERE WAS A RELIANCE ON FOR STAFF; "IT'S OKAY, YOU HAVE A
PAD ON".
NOW THAT'S NOT EXCEPTABLE.
SO WE'RE ACTUALLY ACCESSING PEOPLE.
WE'RE PUTTING THEM INTO MUCH LIGHTER, SMALLER PRODUCTS, WHICH
OF COURSE BRINGS OUR COST DOWN.
WELCOME BACK AND WE'RE SPEAKING WITH PHILIPPA LEWIS, CEO OF
SIMAVITA.
GREAT INSIGHT FROM KAREN IN AUSTRALIA.
YES.
GREAT INFORMATION.
SHE'S A GREAT ADVOCATE OF OUR TECHNOLOGY AND SHE'S A GREAT
USER OF OUR TECHNOLOGY.
TRULY MAKING A DIFFERENCE.
NOW SIMAVITA IS AN AUSTRALIAN COMPANY, SO FOR PEOPLE HERE IN
THE U.S., IS THIS READILY AVAILABLE HERE?
IT'S ABSOLUTELY READILY AVAILABLE.
WE HAVE A GREAT PARTNER HERE
IN THE UNITED STATES.
IT'S A COMPANY CALLED MIDLINE,
AND THEY NOW HAVE EXCLUSIVE RIGHTS TO DISTRIBUTE THIS
PRODUCT ACROSS THE UNITED STATES.
SO ALL YOU HAVE TO DO IS, CLICK ON,
MIDLINE AND YOU'LL GET INFORMATION ABOUT THE TECHNOLOGY
AND CAN ACCESS IT READILY.
AND LET ME ASK YOU SOMETHING, PHILIPPA, ON A PERSONAL NOTE
HERE.
YOU KNOW, INCONTINENCE; IT'S NOT SOMETHING THAT I REALLY HEAR
ABOUT A LOT EVERYDAY AND I THINK IT'S SOMETHING WE
REALLY SHOULD TALK ABOUT MORE, TO BE HONEST.
BECAUSE EVERYBODY, OR MANY PEOPLE ARE GOING TO BE FACED
WITH IT.
AHHH, IS THE MEDIA PARTIALLY TO BLAME FOR THIS LACK OF
AWARENESS?
LOOK, I THINK THE MEDIA PROBABLY ARE PARTIALLY TO BLAME FOR IT.
WE NEED TO RAISE TO AWARENESS- YES.
ABOUT THE SITUATION.
I THINK WHAT PEOPLE FORGET, IS THE
FACT THERE IS THIS ENORMOUS AGING,
WE CALL A TSUNAMI THAT'S COMING THROUGH.
AND PEOPLE HAVE TO THINK OF IT THAT WAY.
IT'S A HUGE CATASTROPHE THAT'S COMING UPON US.
NOW WHEN YOU THINK ABOUT THAT AT LEAST 70% OF
EVERYBODY WHO'S LIVING IN LONG TERM CARE SUFFERS
FROM AN EXTREME FORM OF INCONTINENCE AND THAT THE
COST OF THAT INCONTINENCE IS, BY FAR AND AWAY,
THE BIGGEST COST OF THE CARE OF AN ELDERLY AMERICAN
IN LONG TERM, THEN THIS IS SOMETHING WE SHOULD ALL
BE TALKING ABOUT.
AND THE CAREGIVERS ARE OBVIOUSLY GIVING YOU A LOT OF FEEDBACK
TOO.
CAREGIVERS GIVE US TREMENDOUS FEEDBACK.
IT'S PROBABLY THE NUMBER ONE THING THEY HATE TO DO WHEN THEY
CARE FOR AN ELDERLY PERSON.
YET, THEY DO OFTEN LOVE THEIR JOB.
AND SO, WHEN A CAREGIVER IS TRANSITIONED FROM A MANUAL
PROCESS THAT GIVES THEM VERY BAD DATA,
TO SOMETHING THAT'S REALLY SMART LIKE THIS AND
GIVES THEM FANTASTIC EVIDENCED BASE INFORMATION THAT
THEY CAN GIVE BETTER CARE; HAVE BETTER OUTCOMES FOR THEIR
RESIDENT; THEIR PATIENT AS SUCH.
THEY LOVE IT.
AND IT MAKES A BIG DIFFERENCE TO THEIR
WORKLOAD.
TO THE QUALITY OF THEIR WORK AND THE QUALITY
OF THEIR LIFE AND THE QUALITY OF THE LIFE OF THE PERSON
THAT THEY ARE LOOKING AFTER.
GREAT INFORMATION.
GREAT TECHNOLOGY.
ONE MORE TIME, WHERE CAN WE FIND IT?
MIDLINE.
IF YOU GO TO MIDLINE.COM
YOU WILL FIND THIS TECHNOLOGY AVAILABLE.
THANK YOU SO MUCH- -THANKS OLGA-
-FOR BRING THAT AWARENESS.
I DO APPRECIATE IT.
AND OF COURSE, IF YOU'D LIKE MORE INFORMATION ON TODAY'S
TOPIC OR ANYTHING ELSE FOR THAT MATTER,
JUST GO TO OUR WEBSITE, THAT'S THEBALANCINGACT.COM
THEBALANCINGACT.COM OR LOG ON AND SHARE WITH US YOUR
THOUGHTS AT FACEBOOK/THEBALANCINGACTFANS
. (MUSIC)
PSORIASIS IS A LIFELONG CHRONIC SKIN CONDITION
THAT EFFECTS NEARLY 7.5 MILLION AMERICANS.
80% OF THESE PATIENTS HAVE CHRONIC PLAQUE PSORIASIS.
LIVING WITH AND MANAGING PLAQUE PSORIASIS CAN BE A
TREMENDOUS BURDEN ON ONE'S LIFE.
WITH US THIS MORNING TO DISCUSS THIS DEBILITATING DISEASE
AND WHAT CAN BE TOPICALLY TO HELP MANAGE PSORIASIS,
IS DR.
REBECCA SMITH, A BOARD CERTIFIED DERMATOLOGIST
IN BOTH DERMATOLOGY AND PEDIATRIC DERMATOLOGY.
SHE'S ALSO BASED IN FORT MILL SOUTH CAROLINA AND WAS
VOTED BY CHARLOTTE MAGAZINE AS ONE OF THE TOP DOCTORS
IN THE CHARLOTTE METROPOLITAN AREA.
GOOD MORNING.
THANKS FOR HAVING ME.
CONGRATULATIONS TO YOU.
THANK YOU VERY MUCH.
YOU MUST'VE BEEN SO HONORED.
ABSOLUTELY.
WOW, OBVIOUSLY YOU WORK VERY, VERY TO EARN THAT.
YES MA'AM.
LET'S TALK ABOUT PSORIASIS, MORE SPECIFICALLY
PLAQUE PSORIASIS.
TELL ME ABOUT THIS CONDITION AND WHAT IT IS.
PSORIASIS IS A CHRONIC INFLAMMATORY SKIN DISEASE THAT
OFTEN EFFECTS...IT WILL SHOW UP ON THE ELBOWS AND THE KNEES.
IT'S UMM, PINK TO RED PLAQUES.
THEY'RE OFTEN PRETTY THICK.
THEY HAVE SOME SILVERY SCALE.
IT CAN BE VERY, VISIBLE.
IT CAN CAUSE A LOT OF FRUSTRATION AND A LOF
EMBARRASSMENT TO PATIENTS.
IT CAN ACTUALLY BE ANYWHERE ON THE BODY.
IT CAN BE REALLY FLAKY ON THE SCALP, IT CAN COVER THE
LOWER BACK, THE BUTTOCKS.
IT CAN EVEN EFFECT THE NAILS.
SO IF YOU HAVE A RASH, OR SOME SORT OF SKIN DISEASE
THAT DOESN'T GO AWAY, CONSULT YOUR DERMATOLOGIST TO MAKE
SURE YOU GET THE RIGHT DIAGNOSIS SO YOU CAN GET
THE RIGHT TREATMENT.
THE NATIONAL PSORIASIS FOUNDATION HAS CATEGORIZED
DIFFERENT TYPES OF PSORIASIS AND PLAQUE PSORIASIS IS
THE MOST COMMON TYPE.
IS IT MORE IN MALES, FEMALES, BOTH?
ACTUALLY IN BOTH.
REALLY.
YES MA'AM.
AND IT'S HEREDITARY?
IT IS HEREDITARY.
IT IS NOT CONTAGIOUS.
IT'S HEREDITARY AND ENVIRONMENTAL.
SO FOR PEOPLE WHO SUFFER FROM PLAQUE PSORIASIS,
WHAT ARE SOME OF THE CONCERNS THEY HAVE TO MANAGE
THIS CONDITION.
BECAUSE OBVIOUSLY THERE'S NO CURE.
RIGHT.
THERE'S NO CURE.
SO, WHAT WE WANT; IS WE WANT
SOME EDUCATION AND COMMUNICATION.
SO THE MOST IMPORTANT THING IS TO MAKE AN APPOINTMENT
WITH YOUR DERMATOLOGIST.
YOU NEED A GAME PLAN.
YOU NEED A DISEASE MANAGEMENT STRATEGY.
YOU NEED TO MAKE SURE THAT YOU GET THE RIGHT TREATMENT
FOR YOUR TYPE OF DISEASE.
AND DEPENDING ON THE EXTENT AND SEVERITY OF YOUR DISEASE,
YOU JUST MAY NEED A TOPICAL.
BUT IF YOU HAVE MODERATE TO SEVERE DISEASE, YOU ACTUALLY
MIGHT NEED A SYSTEMIC; AN ORAL MEDICATION OR SOME LIGHT
THERAPY, SOME UV LIGHT THERAPY, CALLED PHOTO THERAPY.
OR YOU MIGHT EVEN NEED A BIOLOGIC.
AN INJECTABLE PROTEIN TO HELP MANAGE YOUR DISEASE.
SO OBVIOUSLY, IT'S NOT THE SAME FOR EVERYBODY.
ABSOLUTELY NOT THE SAME FOR EVERYBODY.
EVERY CASE IS INDIVIDUAL.
DOCTOR, WHAT ARE SOME AVAILABLE TREATMENT OPTIONS TODAY?
WELL, TODAY WE'RE GOING TO FOCUS ON TOPICAL THERAPIES.
OKAY.
AND THERE IS LOTS OF DIFFERENT TOPICAL THERAPIES.
FIRST AND FOREMOST, THE MOST COMMON IS A TOPICAL STEROID.
SO TOPICAL STEROIDS WORK BY DECREASING INFLAMMATION,
BY HELPING WITH THE ITCH, WITH THE THICKNESS OF THE PLAQUE.
IT WILL TAKE THE REDNESS AWAY.
SO TOPICALS STEROIDS HELP WITH INFLAMMATION AND MAKING THE
SYMPTOMS BETTER.
THERE'S CREAMS, THERE'S OINTMENTS, THERE'S GELS, THERE'S
SPRAYS.
MANY OF THE PATIENTS PREFER THE SPRAY FORMULATIONS BECAUSE
OFTEN WITH PSORIASIS, IT'S A LARGE BODY SURFACE AREA.
AND TO COVER IT ALL.
YEAH, TO MAKE IT EASY, TO MAKE IT QUICK, TO MAKE IT CONVENIENT.
THEY WANT SOMETHING THAT'S NOT GONNA' MAKE THEIR CLOTHES MESSY.
SO SPRAYS WILL OFTEN RUB IN AND ABSORB VERY EASILY.
IS THAT WHAT WE HAVE HERE TODAY?
YES, MA'AM.
LET'S TALK ABOUT THIS.
WHAT WE HAVE IS TOPICORT, WHICH IS A SUPER POTENT,
CLASS 1 TOPICAL STEROID.
IT'S FDA APPROVED FOR PLAQUE PSORIASIS IN PATIENTS
18 AND OLDER.
OKAY.
WHAT IT DOES, IS IT DECREASES THE INFLAMMATION OF THE SKIN
AND IN THE CLINICAL TRIALS, ONE OF THE MOST IMPORTANT POINTS
WITH TOPICORT, IS THAT THERE WAS NO STINGING AND BURNING.
EVEN ON THE EXCORIATED PLAQUES.
WHICH MAKES A BIG DIFFERENCE.
ABSOLUTELY.
I KNOW YOU HAVE AN EXAMPLE OF A PATIENT I BELIEVE,
HE'S 35 YEARS OLD AND HE USED IT.
TELL ME WHAT WE'RE SEEING HERE.
YES MA'AM.
SO THIS IS A BASELINE.
THIS PATIENT HAD PSORIASIS FOR 10 YEARS.
AHHHH.
THIS IS A BASELINE PHOTO- THAT LOOKS PAINFUL.
-IT CAN BE VERY PAINFUL; VERY ITCHY.
SO AFTER HE'S APPLIED IT TWICE A DAY FOR TWO WEEKS,
THAT'S THE MIDDLE PHOTO.
AND THEN TWICE A DAY FOR FOUR WEEKS.
SO YOU CAN SEE IT'S NOT CURED, BUT IT'S SIGNIFICANTLY BETTER.
ONE OF MY PATIENTS WAS ACTUALLY AT A SWIMMING POOL ONE TIME
AND HE WAS ASKED TO LEAVE THE SWIMMING POOL BECAUSE PEOPLE
THERE THOUGHT HE HAD SOME CONTAGIOUS DISEASE.
YOU'RE KIDDING!
SO WHAT ABOUT THE SAFETY ASPECT WHEN IT COME TO APPLYING
THIS SPRAY.
BECAUSE, YOU KNOW, IF YOU TELL ME IT'S GOING TO
WORK, I SAY "GREAT" BUT A LOT OF
PEOPLE ARE CONCERNED ABOUT SAFETY.
THE CONNOTATION OF STEROIDS IS SOMETIMES VERY DAUNTING, BUT
IF USED AS DIRECTED BY YOUR PHYSICIAN AND USED FOR NO LONGER
THAN YOUR PHYSICIAN DIRECTS, THEN THEY CAN BE QUITE SAFE AND
EFFECTIVE.
TOPICORT IS FDA APPROVED FOR AGE 18 AND OLDER FOR CHRONIC
PLAQUE PSORIASIS, AND WHAT YOU NEED TO DO, AGAIN IS,
CONSULT YOUR PHYSICIAN.
MAKE SURE THAT YOU ARE ON THE
RIGHT MEDICINE FOR YOUR TYPE OF DISEASE.
ARE THERE RESOURCES FOR PEOPLE OUT THERE THAT MAY BE
SUFFERING FROM PLAQUE PSORIASIS?
BECAUSE A LOT OF PEOPLE ALWAYS WANT TO LEARN MORE.
FAMILIES, EVEN, THAT ARE SUFFERING THROUGH IT WITH
THEIR LOVED ONES.
ABSOLUTELY.
ONE OF MY FAVORITE RESOURCES IS CALLED
THE NATIONAL PSORIASIS FOUNDATION.
IT'S A NONPROFIT.
YOU CAN JOIN IT AS A PATIENT.
YOU CAN JOIN IT AS A PROVIDER.
THEY PROVIDE LOTS OF INFORMATION, SUCH AS,
PAMPHLETS AND BOOKLETS.
THERE'S LOTS OF INFORMATION ONLINE
FOR VARIOUS TREATMENT OPTIONS.
AND ONE OF THE OTHER WONDERFUL RESOURCES FOR MEDICATIONS
LIKE TOPICORT, IS THAT THERE IS CO-PAY CARDS.
SO, THE CO-PAY CARDS MAKE IT FREE FOR THE PATIENTS WHO ARE
INSURED -OH,THAT'S HUGE.
TO RECEIVE THE MEDICATION.
AND AGAIN, HUGE IN TERMS IN MAKING THAT DIFFERENCE.
BECAUSE FROM THE PHOTOS YOU SHOWED ME, AGAIN NO CURE,
BUT WHAT A DIFFERENCE FOR THAT GENTLEMAN.
YES MA'AM.
EXCELLENT.
THANK YOU SO MUCH DOCTOR.
THANK YOU.
AND CONGRATULATIONS AGAIN ON THE HONOR.
THANK YOU.
REALLY PROUD.
MY PLEASURE.
AND OF COURSE, IF YOU'D LIKE MORE INFORMATION ON THIS TOPIC
TODAY, OR ANY KIND OF INFORMATION ON
PLAQUE PSORIASIS, JUST VISIT US AT
THEBALANCINGACT.COM THAT'S
THEBALANCINGACT.COM (MUSIC)
TOPICORT TOPICAL SPRAY, .25% IS A PRESCRIPTION MEDICINE
USED TO TREAT PLAQUE PSORIASIS IN ADULTS 18 YEARS OF AGE
AND OLDER.
TOPICORT TOPICAL SPRAY HAS NOT BEEN STUDIED
IN CHILDREN UNDER 18 YEARS OF AGE.
USE IN CHILDREN UNDER 18 IS NOT RECOMMENDED.
TOPICORT SPRAY SHOULD BE USED FOR THE SHORTEST AMOUNT OF TIME
NEEDED TO TREAT PSORIASIS.
TELL YOUR DOCTOR IF YOUR
CONDITION HAS NOT IMPROVED.
YOU SHOULD NOT USE TOPICORT SPRAY
FOR LONGER THAN FOUR WEEKS.
WHEN USING TOPICORT SPRAY, YOU SHOULD
NOT BANDAGE, COVER OR WRAP THE TREATED SKIN AREA.
TOPICORT SPRAY CAN PASS THROUGH YOUR
SKIN.
TOO MUCH TOPICORT SPRAY PASSING
THROUGH YOUR SKIN CAN EFFECT THE FUNCTION OF YOUR ADRENAL GLANDS.
YOUR DOCTOR MAY DO BLOOD TESTS TO CHECK FOR ADRENAL GLAND
PROBLEMS.
ADRENAL GLAND FUNCTION TYPICALLY RETURNS TO NORMAL AFTER
STOPPING TREATMENT WITH A CORTICOSTEROID.
THE MOST COMMON SIDE EFFECTS OF TOPICORT SPRAY
INCLUDE DRYNESS, IRRITATION AND ITCHY OF SKIN AT THE
TREATED SIGHT.
THESE ARE NOT ALL THE POSSIBLE SIDE EFFECTS OF
TOPICORT SPRAY.
TELL YOUR DOCTOR IF YOU HAVE ANY SIDE EFFECTS
THAT DO NOT GO AWAY.
(MUSIC) SO MUCH GREAT INFORMATION ON
TODAY'S SHOW.
BE SURE TO CHECK OUT OUR WEBSITE,
THEBALANCINGACT.COM AS WELL.
THERE'S SO MUCH THERE FOR YOU.
LOTS THERE.
AND DON'T FORGET ABOUT FACEBOOK AND TWITTER.
LOOK US UP AND WE WILL SEE AGAIN VERY SOON.
REMEMBER TO FIND YOUR BALANCE.
(MUSIC) .